NCT06722534 2025-05-30
Celecoxib for Prevention of Progression in Peutz-Jeghers Syndrome
Air Force Military Medical University, China
Phase NA Recruiting
Clinical Trials
6 trialsNCT00596219 2015-12-23
Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00084370 2013-08-22
Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy
University of Alabama at Birmingham
Phase NA Withdrawn
NCT00084578 2013-07-15
Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder
Fox Chase Cancer Center
Phase NA Withdrawn
NCT00653250 2013-05-21
Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
Vanderbilt-Ingram Cancer Center
Phase NA Completed
NCT00608595 2013-03-05
Celecoxib in Treating Patients With Early-Stage Rectal Cancer
Vanderbilt-Ingram Cancer Center
Phase NA Terminated